| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 75.445 | 167.046 | 49.168 | 16.280 | 18.128 | 12.464 |
| Total Income - EUR | - | - | - | - | 75.445 | 167.046 | 49.168 | 16.280 | 18.128 | 12.464 |
| Total Expenses - EUR | - | - | - | - | 63.273 | 155.499 | 45.082 | 30.737 | 17.190 | 16.128 |
| Gross Profit/Loss - EUR | - | - | - | - | 12.172 | 11.547 | 4.086 | -14.457 | 938 | -3.664 |
| Net Profit/Loss - EUR | - | - | - | - | 11.295 | 9.998 | 3.343 | -14.612 | 766 | -3.664 |
| Employees | - | - | - | - | 1 | 10 | 3 | 1 | 1 | 1 |
Check the financial reports for the company - Nicomed Consult S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 2.100 | 3.443 | 2.313 | 1.169 | 503 |
| Current Assets | - | - | - | - | 13.988 | 48.856 | 27.631 | 7.858 | 2.472 | 3.657 |
| Inventories | - | - | - | - | 19 | 1.052 | 3.572 | 0 | 25 | 163 |
| Receivables | - | - | - | - | 13.543 | 23.029 | 6.743 | 0 | 526 | 840 |
| Cash | - | - | - | - | 426 | 24.775 | 17.317 | 7.858 | 1.922 | 2.654 |
| Shareholders Funds | - | - | - | - | 11.337 | 21.120 | 19.952 | 57 | 823 | -2.845 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 2.651 | 29.836 | 11.122 | 10.113 | 2.818 | 7.005 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8553 - 8553" | |||||||||
| CAEN Financial Year |
8553
|
|||||||||
Comments - Nicomed Consult S.r.l.